Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05881356 · ClinicalTrials.gov registry record
Discovering Factors in the Clinical Study Journey of Patients With OCD
A clinical trial of Obsessive - Compulsive Disorder and OCD, sponsored by Power Life Sciences.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT05881356 is a study of Obsessive - Compulsive Disorder and OCD that is actively recruiting participants, run by Power Life Sciences. The registered enrollment target is 500 participants, below the 2,059-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05881356, a study of Obsessive - Compulsive Disorder and OCD, is actively recruiting participants, sponsored by Power Life Sciences.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
This research aims to collect comprehensive data on the clinical trial experience of OCD patients. Its goal is to identify the factors that limit patients' ability to join or complete a trial successfully. Clinical trial participation often favors specific demographic groups, and limited research exists on the impact of trial attributes on participation. Therefore, this study aims to analyze data from various demographic groups and identify any recurring trends that could provide valuable insights for future OCD patients.
Conditions Studied
Study Locations (1)
California
- Power Life Sciences - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2024-06 |
| Est. Completion | 2026-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05881356
The ClinicalTrials.gov registry entry for NCT05881356 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,059-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (76% lower). The listed sponsor is Power Life Sciences, which has 62 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Obsessive - Compulsive Disorder appearing as the primary indexed condition, and to 0 interventions.
NCT05881356 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05881356 about?
NCT05881356 is a clinical study titled "Discovering Factors in the Clinical Study Journey of Patients With OCD". This research aims to collect comprehensive data on the clinical trial experience of OCD patients. Its goal is to identify the factors that limit patients' ability to join or complete a trial successfully. Clinical trial participation often favors specific demographic groups, and limited research ex...
What is the current status of trial NCT05881356?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2024-06. Estimated completion is 2026-06.
What conditions does trial NCT05881356 study?
This clinical trial studies the following conditions: Obsessive - Compulsive Disorder, OCD.
Who is sponsoring clinical trial NCT05881356?
This trial is sponsored by Power Life Sciences, which has 62 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05881356 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obsessive - Compulsive Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Transcranial Magnetic Stimulation and Psychotherapy for Treating Obsessive-Compulsive Disorder
RECRUITING · NA
-
Mechanisms of Exposure Therapy for OCD
RECRUITING · NA
-
Using Personalized Assessments in the Treatment of Childhood OCD
RECRUITING · NA
-
Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD
RECRUITING · Phase 1
-
Neural Mechanisms of Response Inhibition Training for OCRD
RECRUITING · NA
-
MDMA-Assisted CBT for OCD (MDMA-CBT4OCD Study)
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.